Hospitalised COVID-19 patients with hyperglycemia also presented a higher prevalence of insulin resistance when compared to ARDS (acute respiratory distress syndrome)-positive and ARDS-negative controls, due to changes in adipokine levels (adiponectin and leptin), instead of beta-cell function54. Here, ADIPOQ is linked to COVID-19.